H.C. Wainwright Reiterates Buy Rating on Citius Pharmaceuticals (CTXR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: CTXR) | Delayed: 0.40 +0.03 (8.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.37 | 52 Week High | $2.50 | |||
| Open | $0.38 | 52 Week Low | $0.40 | |||
| Day High | $0.41 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $0.00 | |||
| Volume | 435,499 | |||||
